4//SEC Filing
COVINO GREGORY F 4
Accession 0001127602-18-008813
CIK 0000875045other
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 6:24 PM ET
Size
11.0 KB
Accession
0001127602-18-008813
Insider Transaction Report
Form 4
BIOGEN INC.BIIB
COVINO GREGORY F
VP, Chief Accounting Officer
Transactions
- Tax Payment
Common Stock
2018-02-23$292.78/sh−28$8,198→ 4,744.36 total - Exercise/Conversion
Common Stock
2018-02-23+92→ 4,772.36 total - Exercise/Conversion
Restricted Stock Unit
2018-02-23−92→ 116 totalExercise: $0.00Exp: 2018-02-23→ Common Stock (92 underlying) - Other
Restricted Stock Unit
2018-02-23−116→ 0 totalExercise: $0.00Exp: 2018-02-23→ Common Stock (116 underlying)
Footnotes (2)
- [F1]The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date]).
- [F2]This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested.
Documents
Issuer
BIOGEN INC.
CIK 0000875045
Entity typeother
Related Parties
1- filerCIK 0001224116
Filing Metadata
- Form type
- 4
- Filed
- Feb 26, 7:00 PM ET
- Accepted
- Feb 27, 6:24 PM ET
- Size
- 11.0 KB